Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Non Squamous Lung Cancer × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5112 Lung Neoplasms 3303 Small Cell Lung Carcinoma 885 Breast Neoplasms 588 Neoplasms 561 Colorectal Neoplasms 487 Melanoma 410 Ovarian Neoplasms 377 Neoplasm Metastasis 368 Pancreatic Neoplasms 340 Stomach Neoplasms 286 Adenocarcinoma of Lung 276 Carcinoma, Renal Cell 268 Squamous Cell Carcinoma of Head and Neck 267 Head and Neck Neoplasms 260 Mesothelioma, Malignant 257 Prostatic Neoplasms 252 Esophageal Neoplasms 226 Mesothelioma 216 Colonic Neoplasms 198 Brain Neoplasms 194 Urinary Bladder Neoplasms 185 Triple Negative Breast Neoplasms 183 Uterine Cervical Neoplasms 171 Sarcoma 150 Endometrial Neoplasms 150 Carcinoma, Hepatocellular 130 NSCLC 123 Carcinoma 115 Kidney Neoplasms 109

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01154140 2017-11-06

PROFILE 1014

Pfizer

Phase 3 Completed

343 enrolled 31 charts

Non Squamous Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡